These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 38638439)
1. Bruton's tyrosine kinase inhibition limits endotoxic shock by suppressing IL-6 production by marginal zone B cells in mice. Kawata K; Hatano S; Baba A; Imabayashi K; Baba Y Front Immunol; 2024; 15():1388947. PubMed ID: 38638439 [TBL] [Abstract][Full Text] [Related]
2. Bruton's Tyrosine Kinase Inhibition Attenuates the Cardiac Dysfunction Caused by Cecal Ligation and Puncture in Mice. O'Riordan CE; Purvis GSD; Collotta D; Chiazza F; Wissuwa B; Al Zoubi S; Stiehler L; Martin L; Coldewey SM; Collino M; Thiemermann C Front Immunol; 2019; 10():2129. PubMed ID: 31552054 [TBL] [Abstract][Full Text] [Related]
3. Bruton's tyrosine kinase inhibition induces rewiring of proximal and distal B-cell receptor signaling in mice. Rip J; de Bruijn MJW; Neys SFH; Singh SP; Willar J; van Hulst JAC; Hendriks RW; Corneth OBJ Eur J Immunol; 2021 Sep; 51(9):2251-2265. PubMed ID: 34323286 [TBL] [Abstract][Full Text] [Related]
4. Bruton's tyrosine kinase (BTK) inhibitors alter blood glucose and insulin in obese mice but reduce inflammation independent of BTK. Chan DY; Barra NG; Fang H; Rodrigues E-Lacerda R; Schertzer JD Am J Physiol Endocrinol Metab; 2024 Sep; 327(3):E271-E278. PubMed ID: 39017678 [TBL] [Abstract][Full Text] [Related]
5. X-Linked Immunodeficient Mice With No Functional Bruton's Tyrosine Kinase Are Protected From Sepsis-Induced Multiple Organ Failure. O'Riordan CE; Purvis GSD; Collotta D; Krieg N; Wissuwa B; Sheikh MH; Ferreira Alves G; Mohammad S; Callender LA; Coldewey SM; Collino M; Greaves DR; Thiemermann C Front Immunol; 2020; 11():581758. PubMed ID: 33162995 [TBL] [Abstract][Full Text] [Related]
9. CD38-mediated Inhibition of Bruton's Tyrosine Kinase in Macrophages Prevents Endotoxemic Lung Injury. Farahany J; Tsukasaki Y; Mukhopadhyay A; Mittal M; Nepal S; Tiruppathi C; Malik AB Am J Respir Cell Mol Biol; 2022 Feb; 66(2):183-195. PubMed ID: 34706199 [TBL] [Abstract][Full Text] [Related]
10. Bruton's tyrosine kinase mediates NF-kappa B activation and B cell survival by B cell-activating factor receptor of the TNF-R family. Shinners NP; Carlesso G; Castro I; Hoek KL; Corn RA; Woodland RT; Scott ML; Wang D; Khan WN J Immunol; 2007 Sep; 179(6):3872-80. PubMed ID: 17785824 [TBL] [Abstract][Full Text] [Related]
11. Bruton's Tyrosine Kinase-Mediated Signaling in Myeloid Cells Is Required for Protective Innate Immunity During Pneumococcal Pneumonia. de Porto AP; Liu Z; de Beer R; Florquin S; Roelofs JJTH; de Boer OJ; den Haan JMM; Hendriks RW; van 't Veer C; van der Poll T; de Vos AF Front Immunol; 2021; 12():723967. PubMed ID: 34552589 [TBL] [Abstract][Full Text] [Related]
12. Targeting Bruton's Tyrosine Kinase Across B-Cell Malignancies. da Cunha-Bang C; Niemann CU Drugs; 2018 Nov; 78(16):1653-1663. PubMed ID: 30390220 [TBL] [Abstract][Full Text] [Related]
13. Bruton's tyrosine kinase is a Toll/interleukin-1 receptor domain-binding protein that participates in nuclear factor kappaB activation by Toll-like receptor 4. Jefferies CA; Doyle S; Brunner C; Dunne A; Brint E; Wietek C; Walch E; Wirth T; O'Neill LA J Biol Chem; 2003 Jul; 278(28):26258-64. PubMed ID: 12724322 [TBL] [Abstract][Full Text] [Related]
14. Marginal zone B cells exacerbate endotoxic shock via interleukin-6 secretion induced by Fcα/μR-coupled TLR4 signalling. Honda S; Sato K; Totsuka N; Fujiyama S; Fujimoto M; Miyake K; Nakahashi-Oda C; Tahara-Hanaoka S; Shibuya K; Shibuya A Nat Commun; 2016 May; 7():11498. PubMed ID: 27146354 [TBL] [Abstract][Full Text] [Related]
16. Bruton's Tyrosine Kinase inhibition by Acalabrutinib does not affect early or advanced atherosclerotic plaque size and morphology in Ldlr Hemme E; Biskop D; Depuydt MAC; Smit V; Delfos L; Bernabé Kleijn MNA; Foks AC; Kuiper J; Bot I Vascul Pharmacol; 2023 Jun; 150():107172. PubMed ID: 37075932 [TBL] [Abstract][Full Text] [Related]
17. Distinct Roles for Bruton's Tyrosine Kinase in B Cell Immune Synapse Formation. Roman-Garcia S; Merino-Cortes SV; Gardeta SR; de Bruijn MJW; Hendriks RW; Carrasco YR Front Immunol; 2018; 9():2027. PubMed ID: 30237801 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of Bruton's Tyrosine Kinase Activity Attenuates Hemorrhagic Shock-Induced Multiple Organ Dysfunction in Rats. Patel NM; Oliveira FRMB; Ramos HP; Aimaretti E; Alves GF; Coldewey SM; Collino M; Sordi R; Thiemermann C Ann Surg; 2023 Mar; 277(3):e624-e633. PubMed ID: 35129479 [TBL] [Abstract][Full Text] [Related]
19. Observations on the use of Bruton's tyrosine kinase inhibitors in SAR-CoV-2 and cancer. Benner B; Carson WE J Hematol Oncol; 2021 Jan; 14(1):15. PubMed ID: 33441177 [TBL] [Abstract][Full Text] [Related]
20. Bruton's tyrosine kinase inhibitor suppresses imiquimod-induced psoriasis-like inflammation in mice through regulation of IL-23/IL-17A in innate immune cells. Nadeem A; Ahmad SF; Al-Harbi NO; El-Sherbeeny AM; Alasmari AF; Alanazi WA; Alasmari F; Ibrahim KE; Al-Harbi MM; Bakheet SA; Attia SM Int Immunopharmacol; 2020 Mar; 80():106215. PubMed ID: 31982823 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]